PAUF as a target for treatment of high PAUF-expressing ovarian cancer

Elevated expression of JMJD5 protein due to decreased miR-3656 levels contributes to cancer stem cell-like phenotypes under overexpression of cancer upregulated gene 2

Overexpression of cancer upregulated gene 2 (CUG2) decreases Spry2 through c-Cbl, leading to activation of EGFR and β?catenin signaling

Phosphofructokinase 1 platelet isoform promotes β-catenin transactivation for tumor development

Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes sternness-like properties via the NPM1-TGF-beta signaling axis

CGK062, a small chemical molecule, inhibits cancer upregulated gene 2-induced oncogenesis through NEK2 and beta-catenin

Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells

STAT1-HDAC4 signaling induces epithelial-mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2

Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer

Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling